Senile plaques

WikiDoc Resources for Senile plaques
Articles
Most recent articles on Senile plaques Most cited articles on Senile plaques Review articles on Senile plaques Articles on Senile plaques in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Senile plaques Images of Senile plaques Photos of Senile plaques Podcasts & MP3s on Senile plaques Videos on Senile plaques
Evidence Based Medicine
Cochrane Collaboration on Senile plaques Bandolier on Senile plaques TRIP on Senile plaques
Clinical Trials
Ongoing Trials on Senile plaques at Clinical Trials.gov Trial results on Senile plaques Clinical Trials on Senile plaques at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Senile plaques NICE Guidance on Senile plaques NHS PRODIGY Guidance FDA on Senile plaques CDC on Senile plaques
Books
Books on Senile plaques
News
Senile plaques in the news Be alerted to news on Senile plaques News trends on Senile plaques
Commentary
Blogs on Senile plaques
Definitions
Definitions of Senile plaques
Patient Resources / Community
Patient resources on Senile plaques Discussion groups on Senile plaques Patient Handouts on Senile plaques Directions to Hospitals Treating Senile plaques Risk calculators and risk factors for Senile plaques
Healthcare Provider Resources
Symptoms of Senile plaques Causes & Risk Factors for Senile plaques Diagnostic studies for Senile plaques Treatment of Senile plaques
Continuing Medical Education (CME)
CME Programs on Senile plaques
International
Senile plaques en Espanol Senile plaques en Francais
Business
Senile plaques in the Marketplace Patents on Senile plaques
Experimental / Informatics
List of terms related to Senile plaques

Senile plaques (syn. neuritic plaques, senile druse, braindruse) are extracellular deposits of amyloid in the gray matter of the brain. The deposits are associated with degenerative neural structures and an abundance of microglia and astrocytes. Large numbers of senile plaques and neurofibrillary tangles are characteristic features of Alzheimer’s disease.

senile plaques (silver impregnation)

The plaques are variable in shape and size, but are on the average 50 µm in size. (Franke, M.) In Alzheimer's disease they are primarily composed of amyloid beta peptides. These polypetides tend to aggregate and are believed to be neurotoxic.

Verification

Senile plaques are visible in light microscopy after staining by silver, Congo red, Thioflavin, Kresylviolett, PAS-reaction, and by fluorescence and immunofluorescence microscopy.

Occurrence

Senile plaques can be found in human and animal brains (e.g. mammals and birds). From an age of 60 years (10%) to an age of 80 years (60%) the proportion of people with plaques increases approximately linearly. A small number of plaques can be due to the physiological process of aging. Women are slightly more likely to have plaques than males (Franke, M.). The plaques occur commonly in the amygdoid nucleus and the sulci of the cortex of brain.

History

Blocq and Marinesco first described plaques in the grey matter in 1892. Because of their similarity to the actinomyces druses they were called druse necrosis by O. Fischer in the beginning of the 20th century. The connection of plaques and demential illness was discovered by Alzheimer in 1906. Bielschowsky supposed in 1911 the amyloid-nature of the plaques. Wisniewski denominated them neuritic plaques in 1973. The second half of the 20th century saw proposed theories of immunological and genetic factors in plaque formation (Katenkamp, Op den Velde und Stam). Statistically investigations were performed by J.A.N. Corsellis and M. Franke in the 1970s. M. Franke showed that a demential disease is likely when the number of senile plaques in the frontal cortex is more than 200/mm³. In 1985 succeeded the biochemical identification of amyloid beta. But there are more unsolved questions of formation and importance of the plaque formation.

Importance

The senile plaques are an important criterion of the neuropathological-histological verification of the Alzheimer’s disease; other factors in verification include pathological neurofibrillaries, tangles, atrophic brain with hydrocephalus, and other degenerative signs. The formation and the distribution of the pathological neurofibrillaries have a regularity (H. Braak and E. Braak) and allows to stage the disease. In combination with the occurrence of a great number of plaques the Alzheimer’s disease can diagnosed with high probability.

Literature

• FRANKE, MANFRED: Statistische Untersuchungen über die senilen Drusen im menschlichen Gehirn (zum Problem der Hirndrusenkrankheit). Statistical investigation of the senile plaques in human brains - 1975. Berlin, Akad. für Ärztl. Fortbildung d. DDR, Diss. B, 1976. Deutsche Nationalbiografie Signatur: DBF H 76/10016, IDN: 801313783 Thesen zur Dissertation
• BRAAK, H., E. BRAAK, J. BOHL: Staging of Alzheimer-related cortical destruction. European Neurology, Basel, 1993, 33: 403-408.
• JELLINGER, K.A.: Neurodegenerative Erkrankungen (ZNS) - Eine aktuelle Übersicht. Journal für Neurologie, Neurochirurgie und Psychiatrie 2005; 6 (1), 9-18
• CRUZ, L.; B. URBANC: Aggregation and disaggregation of senile plaques in Alzheimer disease. Proc. Natl. Acad. Sci. USA Vol. 94, pp. 7612±7616, July 1997 Neurobiology

Template:WikiDoc Sources